Hass

하스 · 450330

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$32.7M (₩45.2B)

Overview

Hass makes dental restoration materials, the blocks and blanks that dentists and dental labs mill into crowns, veneers, and other tooth replacements.

Its core products are lithium disilicate glass-ceramics and zirconia, two advanced ceramic materials prized for their strength and natural-looking appearance. Listed on KOSDAQ, Korea's tech and small-cap board, the company's product range centres on its Amber Mill line, a high-strength aesthetic material based on nano-scale lithium disilicate technology designed to mimic the colour and translucency of natural teeth.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$12M
▲ +2.6% YoY
Operating profit · FY2025
US$654.2K
▼ −27.1% YoY
Net income · FY2025
US$1.1M
▼ −13.6% YoY

Revenue

  • FY2024US$11.7M
  • FY2025US$12M

Operating profit

  • FY2024US$897.1K
  • FY2025US$654.2K

Net income

  • FY2024US$1.3M
  • FY2025US$1.1M

Key ratios (FY2025)

ROE
3.3%
Debt/Eq
18.3%
Op. margin
5.4%
Net margin
9.3%
Rev. YoY
▲ +2.6%

Why it matters

Hass claims to be the first Korean company to have successfully developed and mass-produced a lithium silicate glass-ceramic material for dental prosthetic restorations.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.